Journal
JOURNAL OF CLINICAL VIROLOGY
Volume 146, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.jcv.2021.105052
Keywords
Persistence SARS-CoV-2 antibodies; Antibody avidity; Sensitivity; Specificity; COVID-19; neutralization
Categories
Ask authors/readers for more resources
This study evaluated the variation and duration of SARS-CoV-2 antibodies in patients with different severity levels of COVID-19. The results showed that testing for TAb and S/RBD provided the highest sensitivity and longest detection duration. Severe COVID-19 correlated with earlier and higher antibody response, while mild COVID-19 had a wider range of antibody reactivity.
Background: Antibody detection of SARS-CoV-2 requires an understanding of its variation, course, and duration. Methods: Antibody response to SARS-CoV-2 was evaluated over 5-430 days on 828 samples across COVID-19 severity levels, for total antibody (TAb), IgG, IgA, IgM, neutralizing antibody (NAb), antibody avidity, and for receptor-binding-domain (RBD), spike (S), or nucleoprotein (N). Specificity was determined on 676 pre-pandemic samples. Results: Sensitivity at 30-60 days post symptom onset (pso) for TAb-S/RBD, TAb-N, IgG-S, IgG-N, IgA-S, IgM-RBD, and NAb was 96.6%, 99.5%, 89.7%, 94.3%, 80.9%, 76.9% and 92.8%, respectively. Follow-up 430 days pso revealed: TAb-S/RBD increased slightly (100.0%); TAb-N decreased slightly (97.1%); IgG-S and IgA-S decreased moderately (81.4%, 65.7%); NAb remained positive (94.3%), slightly decreasing in activity after 300 days; there was correlation with IgG-S (Rs = 0.88) and IgA-S (Rs = 0.71); IgG-N decreased significantly from day 120 (15.7%); IgM-RBD dropped after 30-60 days (22.9%). High antibody avidity developed against S/RBD steadily with time in 94.3% of patients after 430 days. This correlated with persistent antibody detection depending on antibody-binding efficiency of the test design. Severe COVID-19 correlated with earlier and higher antibody response, mild COVID-19 was heterogeneous with a wide range of antibody reactivities. Specificity of the tests was >= 99%, except for IgA (96%). Conclusion: Sensitivity of anti-SARS-CoV-2 assays was determined by test design, target antigen, antibody avidity, and COVID-19 severity. Sustained antibody detection was mainly determined by avidity progression for RBD and S. Testing by TAb and for S/RBD provided the highest sensitivity and longest detection duration of 14 months so far.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available